FDA nominee Scott Gottlieb plans recusals from decisions on many drug firms
March 29, 2017 at 09:09 AM EDT
The Trump administration’s nominee to lead the Food and Drug Administration plans to recuse himself for a year from FDA decisions on more than 20 companies, including some drug giants.
